Watch: The discovery of HCV and why drugs like Gilead’s Sovaldi are the center of an economic debate

Profiles in Innovation: 
The Discovery of HCV 

Topic Description

Thirty years ago patients who received a blood transfusion had a 30% chance of contracting hepatitis infection, in this video Dr. Harvey Alter, whose research led to the discovery of hepatitis C will discuss his work and the history of HCV.

We also examine how Chiron’s secret six-year effort led to the tests that virtually eliminated the virus from the blood supply, why drugs like Gilead’s Sovaldi are the center of an economic debate on the treatment of HCV, and envision a world in which HCV has been eradicated.

And we talk with Dr. Steven Pearson , who led a health technology assessment of Sovaldi.

Click here to view video